Table 4.

Distribution of N0D2 SNP results in test and control patients.

N0D2 variant	Test Patients (n=10)	Control Patients (n=12)	P value
P268S	4 (40.0)*	6 (50.0)	0.6914
R702W	1 (10.0)	1 (8.3)	1.000
G908R	1 (10.0)	0	0.4545
1000fs	0	0	1.000
At least 1 main risk allele#	2 (20.0)	1 (8.3)	0.571

^*Number of individuals (percentage); for P268S in the FHx IBD group, one individual was homozygous for the variant allele; for all other data, carriers were heterozygous for the variant allele

^#R702W, G908R or 1000fs; there were no individuals who carried the main risk alleles as compound heterozygotes